Plavix Pharmacogenomic Label Update May Help Lilly With Effient Launch
Executive Summary
When Lilly's Effient (prasugrel) finally cleared FDA July 10, the first thing everyone noticed is the "black box" warning of a potential increased risk of bleeding associated with the antithrombotic drug